Description
The presence of ALK gene translocation is a predictor of response to therapy with ALK inhibitors in patients with locally advanced and metastatic non-small cell lung cancer.
Period of execution
Within 11 days. The specified time does not include the day of biomaterial collection
Biomaterial type
- Tissue sample
- Tissue sample in paraffin block